Titre : Orange acridine

Orange acridine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Substance Abuse Detection
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Orange acridine : Questions médicales les plus fréquentes", "headline": "Orange acridine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Orange acridine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-12", "dateModified": "2025-04-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Orange acridine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Aminoacridines", "url": "https://questionsmedicales.fr/mesh/D000609", "about": { "@type": "MedicalCondition", "name": "Aminoacridines", "code": { "@type": "MedicalCode", "code": "D000609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.046.250" } } }, "about": { "@type": "MedicalCondition", "name": "Orange acridine", "alternateName": "Acridine Orange", "code": { "@type": "MedicalCode", "code": "D000165", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hiroyuki Tsuchie", "url": "https://questionsmedicales.fr/author/Hiroyuki%20Tsuchie", "affiliation": { "@type": "Organization", "name": "Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan tuchikiti@yahoo.co.jp." } }, { "@type": "Person", "name": "Naohisa Miyakoshi", "url": "https://questionsmedicales.fr/author/Naohisa%20Miyakoshi", "affiliation": { "@type": "Organization", "name": "Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan." } }, { "@type": "Person", "name": "Hiroyuki Nagasawa", "url": "https://questionsmedicales.fr/author/Hiroyuki%20Nagasawa", "affiliation": { "@type": "Organization", "name": "Department of Orthopedic Surgery, Akita University Graduate School of Medicine, Akita, Japan." } }, { "@type": "Person", "name": "Makoto Emori", "url": "https://questionsmedicales.fr/author/Makoto%20Emori", "affiliation": { "@type": "Organization", "name": "Department of Orthopedic Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan." } }, { "@type": "Person", "name": "Kyoji Okada", "url": "https://questionsmedicales.fr/author/Kyoji%20Okada", "affiliation": { "@type": "Organization", "name": "Department of Physical Therapy, Akita University Graduate School of Health Sciences, Akita, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Nail analysis for the assessment of caffeine abuse in Northwest China: A population-based study.", "datePublished": "2023-06-13", "url": "https://questionsmedicales.fr/article/37312428", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/1556-4029.15311" } }, { "@type": "ScholarlyArticle", "name": "Workflow to facilitate the detection of new psychoactive substances and drugs of abuse in influent urban wastewater.", "datePublished": "2024-03-05", "url": "https://questionsmedicales.fr/article/38457976", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jhazmat.2024.133955" } }, { "@type": "ScholarlyArticle", "name": "Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel.", "datePublished": "2023-10-12", "url": "https://questionsmedicales.fr/article/37828494", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13011-023-00566-7" } }, { "@type": "ScholarlyArticle", "name": "Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.", "datePublished": "2023-09-21", "url": "https://questionsmedicales.fr/article/37748427", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.forsciint.2023.111835" } }, { "@type": "ScholarlyArticle", "name": "Kratom: Substance of Abuse or Therapeutic Plant?", "datePublished": "2022-07-31", "url": "https://questionsmedicales.fr/article/36055730", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.psc.2022.04.002" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérocycliques 3 noyaux", "item": "https://questionsmedicales.fr/mesh/D006575" }, { "@type": "ListItem", "position": 5, "name": "Acridines", "item": "https://questionsmedicales.fr/mesh/D000166" }, { "@type": "ListItem", "position": 6, "name": "Aminoacridines", "item": "https://questionsmedicales.fr/mesh/D000609" }, { "@type": "ListItem", "position": 7, "name": "Orange acridine", "item": "https://questionsmedicales.fr/mesh/D000165" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Orange acridine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Orange acridine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Orange acridine", "description": "Comment l'orange acridine est-il utilisé en diagnostic ?\nQuels types de cellules peuvent être colorés avec l'orange acridine ?\nL'orange acridine peut-il détecter des infections ?\nQuelle est la méthode d'application de l'orange acridine ?\nPeut-on utiliser l'orange acridine en cytométrie ?", "url": "https://questionsmedicales.fr/mesh/D000165?mesh_terms=Substance+Abuse+Detection&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Orange acridine", "description": "Quels symptômes peuvent être observés lors de l'utilisation de l'orange acridine ?\nL'orange acridine provoque-t-il des effets secondaires ?\nY a-t-il des symptômes d'allergie à l'orange acridine ?\nL'orange acridine affecte-t-il la vision ?\nQuels symptômes indiquent une surdose d'orange acridine ?", "url": "https://questionsmedicales.fr/mesh/D000165?mesh_terms=Substance+Abuse+Detection&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Orange acridine", "description": "Comment prévenir les irritations dues à l'orange acridine ?\nY a-t-il des précautions à prendre avec l'orange acridine ?\nComment stocker l'orange acridine en toute sécurité ?\nL'orange acridine nécessite-t-il des formations spécifiques ?\nQuelles sont les bonnes pratiques de laboratoire avec l'orange acridine ?", "url": "https://questionsmedicales.fr/mesh/D000165?mesh_terms=Substance+Abuse+Detection&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Orange acridine", "description": "L'orange acridine est-il utilisé en traitement médical ?\nPeut-on utiliser l'orange acridine pour traiter des infections ?\nComment neutraliser l'orange acridine en cas d'exposition ?\nL'orange acridine est-il utilisé en thérapie génique ?\nY a-t-il des alternatives à l'orange acridine ?", "url": "https://questionsmedicales.fr/mesh/D000165?mesh_terms=Substance+Abuse+Detection&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Orange acridine", "description": "Quelles complications peuvent survenir avec l'orange acridine ?\nL'orange acridine peut-il causer des effets à long terme ?\nY a-t-il des risques d'exposition professionnelle à l'orange acridine ?\nComment gérer une exposition accidentelle à l'orange acridine ?\nL'orange acridine est-il cancérigène ?", "url": "https://questionsmedicales.fr/mesh/D000165?mesh_terms=Substance+Abuse+Detection&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Orange acridine", "description": "Qui est à risque d'irritation par l'orange acridine ?\nLes allergies à l'orange acridine sont-elles fréquentes ?\nLes enfants sont-ils plus à risque avec l'orange acridine ?\nLes travailleurs de laboratoire sont-ils exposés à des risques ?\nY a-t-il des groupes vulnérables face à l'orange acridine ?", "url": "https://questionsmedicales.fr/mesh/D000165?mesh_terms=Substance+Abuse+Detection&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment l'orange acridine est-il utilisé en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il permet de visualiser les acides nucléiques dans les cellules par fluorescence." } }, { "@type": "Question", "name": "Quels types de cellules peuvent être colorés avec l'orange acridine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Il est utilisé pour colorer les cellules vivantes et les cellules mortes, notamment les cellules tumorales." } }, { "@type": "Question", "name": "L'orange acridine peut-il détecter des infections ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être utilisé pour identifier des infections virales en colorant les acides nucléiques viraux." } }, { "@type": "Question", "name": "Quelle est la méthode d'application de l'orange acridine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Il est généralement appliqué par immersion ou par ajout direct sur les échantillons cellulaires." } }, { "@type": "Question", "name": "Peut-on utiliser l'orange acridine en cytométrie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est souvent utilisé en cytométrie en flux pour analyser les cellules colorées." } }, { "@type": "Question", "name": "Quels symptômes peuvent être observés lors de l'utilisation de l'orange acridine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "L'orange acridine est généralement sûr, mais peut provoquer une irritation cutanée chez certains." } }, { "@type": "Question", "name": "L'orange acridine provoque-t-il des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires sont rares, mais une exposition prolongée peut causer des irritations." } }, { "@type": "Question", "name": "Y a-t-il des symptômes d'allergie à l'orange acridine ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques peuvent survenir, comme des démangeaisons ou des rougeurs." } }, { "@type": "Question", "name": "L'orange acridine affecte-t-il la vision ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition directe aux yeux peut causer des irritations, mais cela est rare." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose d'orange acridine ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une surdose peut entraîner des nausées ou des vomissements, bien que cela soit rare." } }, { "@type": "Question", "name": "Comment prévenir les irritations dues à l'orange acridine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des gants et des lunettes de protection lors de la manipulation du colorant." } }, { "@type": "Question", "name": "Y a-t-il des précautions à prendre avec l'orange acridine ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter le contact avec la peau et les yeux, et travailler dans un espace ventilé." } }, { "@type": "Question", "name": "Comment stocker l'orange acridine en toute sécurité ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Conserver dans un endroit frais, sombre et hors de portée des enfants." } }, { "@type": "Question", "name": "L'orange acridine nécessite-t-il des formations spécifiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur la manipulation des produits chimiques est recommandée." } }, { "@type": "Question", "name": "Quelles sont les bonnes pratiques de laboratoire avec l'orange acridine ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité." } }, { "@type": "Question", "name": "L'orange acridine est-il utilisé en traitement médical ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il est principalement utilisé pour la recherche et le diagnostic, pas comme traitement direct." } }, { "@type": "Question", "name": "Peut-on utiliser l'orange acridine pour traiter des infections ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, il n'est pas un traitement, mais un outil de diagnostic pour détecter des infections." } }, { "@type": "Question", "name": "Comment neutraliser l'orange acridine en cas d'exposition ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Rincer abondamment à l'eau et consulter un médecin si des symptômes persistent." } }, { "@type": "Question", "name": "L'orange acridine est-il utilisé en thérapie génique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il peut être utilisé pour visualiser les cellules dans des études de thérapie génique." } }, { "@type": "Question", "name": "Y a-t-il des alternatives à l'orange acridine ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, d'autres colorants fluorescents comme le DAPI ou le SYBR Green peuvent être utilisés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'orange acridine ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des irritations cutanées ou oculaires peuvent survenir en cas de contact direct." } }, { "@type": "Question", "name": "L'orange acridine peut-il causer des effets à long terme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études sont nécessaires, mais une exposition prolongée peut être préoccupante." } }, { "@type": "Question", "name": "Y a-t-il des risques d'exposition professionnelle à l'orange acridine ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs en laboratoire doivent suivre des protocoles de sécurité stricts." } }, { "@type": "Question", "name": "Comment gérer une exposition accidentelle à l'orange acridine ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Rincer immédiatement à l'eau et consulter un médecin si des symptômes apparaissent." } }, { "@type": "Question", "name": "L'orange acridine est-il cancérigène ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des études sont en cours, mais il n'y a pas de preuve concluante de cancérogénicité." } }, { "@type": "Question", "name": "Qui est à risque d'irritation par l'orange acridine ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes manipulant fréquemment le colorant sans protection adéquate sont à risque." } }, { "@type": "Question", "name": "Les allergies à l'orange acridine sont-elles fréquentes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les allergies sont rares, mais des individus sensibles peuvent réagir au contact." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque avec l'orange acridine ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sont plus sensibles aux produits chimiques, donc une prudence est nécessaire." } }, { "@type": "Question", "name": "Les travailleurs de laboratoire sont-ils exposés à des risques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils doivent suivre des protocoles de sécurité pour minimiser les risques d'exposition." } }, { "@type": "Question", "name": "Y a-t-il des groupes vulnérables face à l'orange acridine ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes avec des antécédents d'allergies ou d'irritations cutanées sont plus vulnérables." } } ] } ] }

Sources (10000 au total)

Test characteristics of shorter versions of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) for brief screening for problematic substance use in a population sample from Israel.

Substance use is a leading cause of preventable morbidity and mortality worldwide. Population-wide screening for problematic substance use in primary health care may mitigate the serious health and so... General population Jewish adults in Israel (N = 2,474) responded to an online survey that included the ASSIST 3.1 and sociodemographics. Across substances (alcohol, tobacco, cannabis, sedatives, presc... ASSIST-FC scores showed high ability to identify ASSIST 3.1 problematic use, with minimal differences by gender or age. Binary ASSIST-FC (most substances: threshold 3+; alcohol: 5+) showed high specif... The ASSIST-FC, which assesses frequency of use and other's concerns about use, appears useful for very brief screening in primary care to identify patients who may benefit from intervention. Early ide...

Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.

Driving under the influence of drugs (DUID) is a risk factor for traffic accidents. The testing of oral fluid by roadside immunochromatography and laboratory-confirmed chromatography coupled to mass s... We received for confirmation 3051 oral fluid samples from drivers who had tested positive at the roadside with a Drugwipe-5S® device between 2018 and 2021 around Grenoble, France. Samples were collect... Most of the drivers were men (93.2%), with a median age of 26 years (range: 14-66 years). Cannabis (94.6%) cocaine (17.5%) and MDMA (2.5%) were the drugs most frequently detected. Poly-drug use was ob... We report recent trends for drivers testing positive for illicit drugs in oral fluid in France. Cannabis was the most prevalent drug of abuse identified, suggesting that a general prevention program m...

Late-stage borreliosis and substance abuse.

Infectious diseases can contribute to substance abuse. Here, a fatal case of borreliosis and substance abuse is reported. This patient had a history of multiple tick bites and increasing multisystem s... Brain tissue was obtained from autopsy and stained for microglial activation and quinolinic acid (QA). Immunoflouresence (IFA) and fluorescence... Autopsy tissue evaluation demonstrated... Late-stage borreliosis is associated with multiple symptoms that may contribute to an increased risk of substance abuse and addictive disorders. More effective diagnosis and treatment of borreliosis, ...

Use of psychoactive substances by goods carriage drivers associated with Kerala, India.

This study aimed to measure the prevalence of drugs of abuse (DOA) among the goods carriage drivers associated with the southern State of India, Kerala.... Point-of-collection testing (POCT) of oral fluid collected from the participants (... Out of the total samples, 53 (21.29%) were positive for one or more DOA. A high prevalence of tetrahydrocannabinol (THC) (10.04%) and synthetic cannabinoids were detected in the samples. The use of ke... This was the first study conducted among drivers in India for the detection of DOA. Tetrahydrocannabinol (THC) was used more by the goods carriage drivers associated with Kerala State, India. The use ...

The association between abused adults and substance abuse in Taiwan, 2000-2015.

To investigate whether adults suffering from violence were at risk of substance abuse and provides insight into the relationship between male and female abusers and substance abuse from 2000 to 2015 i... This study used data on outpatient, emergency, and inpatient visits for 2 million people enrolled in universal health insurance from 2000 to 2015. ICD-9 diagnosis codes 995.8 (abused adult) and E960-E... A total of 8,726 people suffered violence (control group: 34,904 people) over 15 years. The prevalence of substance abuse among victims of violence was 78.3/10... The risks of substance abuse, after adult violence, are higher than in those who have not suffered violent injuries....

Umbilical Cord Collection and Drug Testing to Estimate Prenatal Substance Exposure in Utah.

Our primary objective was to estimate statewide prenatal substance exposure based on umbilical cord sampling. Our secondary objectives were to compare prevalence of prenatal substance exposure across ... We performed a cross-sectional prevalence study of prenatal substance exposure, as determined by umbilical cord positivity for 49 drugs and drug metabolites, through the use of qualitative liquid chro... From November 2020 to November 2021, 1,748 cords (urban n=988, rural n=384, frontier n=376) were collected from 37 hospitals, representing 92% of hospitals that conduct 91% of births in the state. Mor... Prenatal substance exposure was detected in nearly 1 in 10 births statewide....